Post hoc analysis of GATHER 1 and GATHER 2 (292 avacincaptad pegol 2 mg vs 332 sham eyes with geographic atrophy): avacincaptad pegol reduced growth of total EZ attenuation by 19.5% and partial EZ attenuation by 55.3% vs sham over 12 months.
Secondary analysisn = 624 eyes
Ehlers et al. Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation and Loss in Eyes with Geographic Atrophy